Leading drug maker Torrent Pharma Ltd. on Wednesday reported Rs 337 crore net profit on standalone basis for the first (April-June) quarter of this fiscal (2016-17) as against Rs 839 crore posted in like period year ago, registering 60 per cent year-on-year (YoY) decline.
In a regulatory filing to BSE and NSE, the city-based pharma major said total income also declined 30 per cent YoY for the quarter under review (Q1) to Rs 1,367 crore on standalone basis from Rs 1,943 crore in same period year ago.
On a consolidated basis too, net profit declined 55 per cent YoY to Rs 292 crore in Q1 from Rs 650 crore year ago and total income dipped 22 per cent YoY to Rs 1,571 crore from Rs 2,022 crore year ago.
The company's scrip of Rs 5 face value ended at Rs 1,409.55 per share on BSE, losing Rs 52.55 or 3.5 per cent from Tuesday's closing price of Rs 1,461.75.
Opening at Rs 1,477.85 per share, the scrip touched a high of Rs 1,477.85 and a low of Rs 1,395 during intra-trading session.
--IANS
fb/rn/vt
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
